valsartan has been researched along with Diabetic Neuropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coppey, LJ; Davidson, EP; Obrosov, A; Shevalye, H; Yorek, MA | 1 |
| Coll, JR; Estacio, RO; Schrier, RW; Tran, ZV | 1 |
| Ruilope, LM | 1 |
1 review(s) available for valsartan and Diabetic Neuropathies
| Article | Year |
|---|---|
New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Diabetes Complications; Diabetic Neuropathies; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney Diseases; Renal Insufficiency; Tetrazoles; Valine; Valsartan | 2000 |
1 trial(s) available for valsartan and Diabetic Neuropathies
| Article | Year |
|---|---|
Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Cardiovascular Diseases; Colorado; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Progression; Female; Follow-Up Studies; Humans; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan | 2006 |
1 other study(ies) available for valsartan and Diabetic Neuropathies
| Article | Year |
|---|---|
Vascular and Neural Complications in Type 2 Diabetic Rats: Improvement by Sacubitril/Valsartan Greater Than Valsartan Alone.
Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Diet, High-Fat; Disease Progression; Drug Combinations; Male; Neprilysin; Neural Conduction; Neuroprotective Agents; Protease Inhibitors; Rats, Sprague-Dawley; Tetrazoles; Valsartan; Vascular Resistance | 2018 |